CD4 and CD30 Coexpression in a Cutaneous Manifestation of Systemic Mastocytosis - A Pitfall

被引：1
|
作者：
Kulberg, Aleksandra [1 ]
Mitteldorf, Christina [1 ]
机构：
[1] HELIOS Klin, Dept Dermatol Venereol & Allergol, Hildesheim, Germany
来源：
AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2018年 / 40卷 / 08期
关键词：
MAST-CELLS; EXPRESSION; RECEPTOR; MEMBER;
D O I：
10.1097/DAD.0000000000000895
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：628 / 630
页数：4
相关论文
共 50 条
  • [1] CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
    Morgado, Jose M.
    Perbellini, Omar
    Johnson, Ryan C.
    Teodosio, Cristina
    Matito, Almudena
    Alvarez-Twose, Ivan
    Bonadonna, Patrizia
    Zamo, Alberto
    Jara-Acevedo, Maria
    Mayado, Andrea
    Garcia-Montero, Andres
    Mollejo, Manuela
    George, Tracy I.
    Zanotti, Roberta
    Orfao, Alberto
    Escribano, Luis
    Sanchez-Munoz, Laura
    HISTOPATHOLOGY, 2013, 63 (06) : 780 - 787
  • [2] CD30 Ligand/CD30 Interaction Is Involved in Pathogenesis of Inflammatory Bowel Disease
    Somada, Shinichi
    Muta, Hiromi
    Nakamura, Kazuhiko
    Sun, Xun
    Honda, Kuniomi
    Ihara, Eikichi
    Akiho, Hirotada
    Takayanagi, Ryoichi
    Yoshikai, Yasunobu
    Podack, Eckhard R.
    Tani, Kenzaburo
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (08) : 2031 - 2037
  • [3] Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
    Borate, Uma
    Mehta, Amitkumar
    Reddy, Vishnu
    Tsai, Michaela
    Josephson, Neil
    Schnadig, Ian
    LEUKEMIA RESEARCH, 2016, 44 : 25 - 31
  • [4] CD30 Ligand/CD30 Plays a Critical Role in Th17 Differentiation in Mice
    Sun, Xun
    Yamada, Hisakata
    Shibata, Kensuke
    Muta, Hiromi
    Tani, Kenzaburo
    Podack, Eckhard R.
    Yoshikai, Yasunobu
    JOURNAL OF IMMUNOLOGY, 2010, 185 (04) : 2222 - 2230
  • [5] CD30: a new target for ALL?
    Fathi, Amir T.
    Chen, Yi-Bin
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 478 - 479
  • [6] CD30 Positive Atypical Lymphocytes in Perniosis: A Potential Histopathologic Pitfall in a Benign Condition
    Massey, Paul R.
    Wanat, Kari A.
    Stewart, Campbell L.
    Kim, Ellen J.
    Castelo-Soccio, Leslie
    Elenitsas, Rosalie
    Rubin, Adam I.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2014, 36 (09) : 730 - 733
  • [7] Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors
    Jafarian, Amir Hossein
    Tasbandi, Aida
    Gilan, Hamed
    Sheikhi, Maryam
    Roshan, Nema Mohamadian
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (04) : 500 - 504
  • [8] Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30- Tumors
    Hombach, Andreas A.
    Rappl, Gunter
    Abken, Hinrich
    MOLECULAR THERAPY, 2019, 27 (10) : 1825 - 1835
  • [9] The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice
    Fuchiwaki, Takafumi
    Sun, Xun
    Fujimura, Kenjiro
    Yamada, Hisakata
    Shibata, Kensuke
    Muta, Hiromi
    Podack, Eckhard R.
    Kawauchi, Hideyuki
    Yoshikai, Yasunobu
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (10) : 2947 - 2954
  • [10] CD30: seeing is not always believing
    Blum, Kristie A.
    BLOOD, 2015, 125 (09) : 1358 - 1359
12345